Pharma bodies bat for 'One Molecule One MRP' policy

Representatives of several small and medium pharma companies have suggested that the government adopt a "one molecule-one MRP" formula instead of trade margin rationalisation (TMR) on non-scheduled drugs to reduce their prices.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/vHqFJfZ
via IFTTT